Certain strains of E. coli can outcompete disease-causing microbes for resources.

A pharmaceutical company, Pharmacy Plus has launched Duostam, an advanced treatment for Benign Prostatic Hyperplasia (BPH), also known as prostate enlargement.

Some of these symptoms may slowly develop over time, but if not treated timely, they may become worse. An untreated BPH can ...

Treatment with UGN-102 in patients with recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer demonstrated ...

The condition can cause urine infections as well as chronic and acute urinary retention. Chronic urinary retention is when someone cannot empty their bladder fully. It is usually painless, but can ...

When we added more E. coli than UTI-causing bacteria, which is what we envision for future development and testing, the ...

A new study published in the International Journal of Urology found that prostatic urethral lift (PUL) is a safe and ...

Pharmacy Plus has set a new standard in prostate health care with the launch of Duostam, an innovative treatment for Benign Prostatic Hyperplasia (BPH), ...

Pharmacy Plus, a prominent pharmaceutical company, has launched Duostam, an innovative medication for the treatment of Benign ...

Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of Axonics Inc. after entering into a purchase agreement in January.

As Nigerian men struggle with the challenges of prostate enlargement, a leading pharmaceutical company, Pharmacy Plus, ...